ES2339265T3 - Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de la difuncion erectil. - Google Patents

Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de la difuncion erectil. Download PDF

Info

Publication number
ES2339265T3
ES2339265T3 ES05798477T ES05798477T ES2339265T3 ES 2339265 T3 ES2339265 T3 ES 2339265T3 ES 05798477 T ES05798477 T ES 05798477T ES 05798477 T ES05798477 T ES 05798477T ES 2339265 T3 ES2339265 T3 ES 2339265T3
Authority
ES
Spain
Prior art keywords
carnitine
acid
acetyl
propionyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05798477T
Other languages
English (en)
Spanish (es)
Inventor
Aleardo Koverech
Giorgio Cavallini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2339265T3 publication Critical patent/ES2339265T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES05798477T 2004-11-11 2005-10-19 Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de la difuncion erectil. Expired - Lifetime ES2339265T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM04A0561 2004-11-11
IT000561A ITRM20040561A1 (it) 2004-11-11 2004-11-11 Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.

Publications (1)

Publication Number Publication Date
ES2339265T3 true ES2339265T3 (es) 2010-05-18

Family

ID=35501123

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05798477T Expired - Lifetime ES2339265T3 (es) 2004-11-11 2005-10-19 Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de la difuncion erectil.

Country Status (16)

Country Link
US (1) US8003652B2 (https=)
EP (1) EP1811988B1 (https=)
JP (1) JP5080263B2 (https=)
KR (1) KR101455275B1 (https=)
AT (1) ATE456950T1 (https=)
CA (1) CA2585654C (https=)
CY (1) CY1110239T1 (https=)
DE (1) DE602005019251D1 (https=)
DK (1) DK1811988T3 (https=)
ES (1) ES2339265T3 (https=)
IT (1) ITRM20040561A1 (https=)
MX (1) MX2007005518A (https=)
PL (1) PL1811988T3 (https=)
PT (1) PT1811988E (https=)
SI (1) SI1811988T1 (https=)
WO (1) WO2006050794A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010222347A (ja) * 2009-02-24 2010-10-07 Daiichi Sankyo Healthcare Co Ltd Ｐｄｅ５阻害剤及びカルニチンを含有する医薬組成物
WO2012000634A1 (de) 2010-06-29 2012-01-05 Georg Bambach Pharmazeutische zusammensetzung zur behandlung von erektiler dysfunktion
WO2018070971A1 (ru) * 2016-10-10 2018-04-19 Товарыство З Обмэжэною Видповидальнистю Науково-Выробныча Фирма "Микрохим" Фармацевтическая композиция в форме оромукозного спрея для лечения эректильной дисфункции и легочной артериальной гипертензии

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE462791T1 (de) 1999-08-13 2010-04-15 Deutsches Krebsforsch Parvovirus ns1 varianten
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
JP2001233770A (ja) * 2000-02-23 2001-08-28 Dountsuendorufaa Udo 勃起機能不全治療用の経口薬の組合わせ
ITRM20010621A1 (it) * 2001-10-18 2003-04-18 Aldo Fassi Sali metallici non igroscopici e idrosolubili di alcanoil l-carnitine, integratori dietetici che li contengono e kit dietetici, per contrast
ITRM20010708A1 (it) * 2001-12-04 2003-06-04 Sigma Tau Ind Farmaceuti Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.

Also Published As

Publication number Publication date
EP1811988A1 (en) 2007-08-01
CY1110239T1 (el) 2015-01-14
MX2007005518A (es) 2007-05-18
JP5080263B2 (ja) 2012-11-21
KR20070085961A (ko) 2007-08-27
DK1811988T3 (da) 2010-05-17
CA2585654A1 (en) 2006-05-18
EP1811988B1 (en) 2010-02-03
SI1811988T1 (sl) 2010-10-29
WO2006050794A1 (en) 2006-05-18
PL1811988T3 (pl) 2010-07-30
ATE456950T1 (de) 2010-02-15
US8003652B2 (en) 2011-08-23
DE602005019251D1 (de) 2010-03-25
PT1811988E (pt) 2010-04-08
CA2585654C (en) 2013-04-02
KR101455275B1 (ko) 2014-10-27
JP2008531466A (ja) 2008-08-14
US20080090906A1 (en) 2008-04-17
ITRM20040561A1 (it) 2005-02-11

Similar Documents

Publication Publication Date Title
US20050196434A1 (en) Pharmaceutical composition and method for the transdermal delivery of magnesium
US20070292493A1 (en) Pharmaceutical composition and method for the transdermal delivery of calcium
ES2706493T3 (es) Complejos de aminoácidos minerales de agentes activos
JP5788527B2 (ja) キナーゼ阻害剤の副作用低減剤
CN101939000A (zh) 用于治疗病理性眼部血管增生的物质和方法
JP2024546605A (ja) がんを治療するための併用療法の使用
ES2535401T3 (es) Composiciones para el tratamiento de enfermedades neoplásicas
US20170319519A1 (en) Combination for the treatment of conditions involving muscular pain
US20170119841A1 (en) Amino acid salts of unsaturated fatty acids
ES2339265T3 (es) Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de la difuncion erectil.
US11596166B2 (en) Compositions and methods for treating aging and/or improving human health
WO2019146735A1 (ja) 侵害受容性疼痛の予防又は改善用組成物
ES2322455T3 (es) Uso de carnitinas para la prevencion y/o tratamiento de trastornos producidos por la andropausia.
US20110117070A1 (en) Compositions and methods for treating headache
BR112021015682A2 (pt) Combinação de silício e magnésio para a prevenção e tratamento contra cãibras musculares
JP6625986B2 (ja) カカオポリフェノール及び好酸球性食道炎の治療又は予防におけるその使用
US7776913B2 (en) Carnitines for treating or preventing disorders caused by andropause
TW202239401A (zh) 正丁基苯酞於促進脂肪褐變、以及預防或治療脂肪肝及相關肝病變之應用
WO2026028044A1 (en) A bioactive peptide composition
RU2336878C2 (ru) Средство для лечения эректильной дисфункции